Home / Inspections / 716404

FDA Inspection 716404 — Smithfield Bioscience Inc

Smithfield Bioscience Inc — FEI 1527761

The FDA completed an inspection of Smithfield Bioscience Inc on March 28, 2011 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 28, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cincinnati, OH (United States)

Facility

Other inspections at this facility

  • 1297264 (OAI Tue Dec 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1174658 (VAI Fri Jul 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1091136 (VAI Wed May 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 993873 (VAI Thu Oct 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 905867 (VAI Fri Nov 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

  • Seizure (10788) (Thu Nov 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources